Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1611 1617 1626
This examiner grants 57% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18578485 | SODIUM N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLATE POLYMORPHIC FORM A | Non-Final OA | Novo Nordisk A/S |
| 16170516 | COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT SOLUBLE ANTIDANDRUFF AGENTS | Final Rejection | The Procter & Gamble Company |
| 18729607 | UV FILTER COMPOSITIONS COMPRISING CLOSED-CELL METAL OXIDE PARTICLES | Non-Final OA | BASF SE |
| 18278688 | NEURAL CONTROL OF ADAPTIVE IMMUNITY | Final Rejection | The Feinstein Institutes for Medical Research |
| 18757037 | PRODUCTS AND METHODS FOR ORGAN PROTECTION WITH NOBLE NANOPARTICLES | Non-Final OA | UCHICAGO ARGONNE, LLC |
| 18954915 | Anhydrous Sunscreen Compositions With enhanced Ultraviolet Protection | Non-Final OA | ELC Management LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy